News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
463,636 Results
Type
Article (17207)
Company Profile (146)
Press Release (446283)
Section
Business (149376)
Career Advice (821)
Deals (25494)
Drug Delivery (30)
Drug Development (41899)
Employer Resources (72)
FDA (10325)
Job Trends (9468)
News (229563)
Policy (16578)
Tag
Academia (1396)
Alliances (39352)
Alzheimer's disease (562)
Approvals (10309)
Artificial intelligence (146)
Bankruptcy (184)
Best Places to Work (7651)
Biotechnology (113)
Breast cancer (87)
Cancer (748)
Career advice (717)
Cell therapy (195)
Clinical research (33164)
Collaboration (356)
Compensation (124)
COVID-19 (1210)
C-suite (94)
Data (820)
Diabetes (63)
Diagnostics (5206)
Earnings (58563)
Employer resources (65)
Events (71644)
Executive appointments (262)
FDA (10702)
Funding (298)
Gene therapy (117)
GLP-1 (241)
Government (1456)
Healthcare (12150)
Infectious disease (1260)
Inflammatory bowel disease (63)
Interviews (96)
IPO (11810)
Job creations (2099)
Job search strategy (645)
Layoffs (176)
Legal (3985)
Lung cancer (91)
Manufacturing (121)
Medical device (12028)
Medtech (12033)
Mergers & acquisitions (13810)
Metabolic disorders (169)
Neuroscience (706)
NextGen Class of 2024 (4296)
Non-profit (1947)
Northern California (1079)
Obesity (85)
Opinion (89)
Patents (75)
People (42345)
Phase I (11289)
Phase II (14714)
Phase III (10361)
Pipeline (382)
Postmarket research (990)
Preclinical (4887)
Press Release (72)
Radiopharmaceuticals (189)
Rare diseases (122)
Real estate (4138)
Regulatory (11746)
Research institute (1383)
Resumes & cover letters (123)
Southern California (970)
Startups (2806)
United States (9690)
Vaccines (256)
Date
Today (89)
Last 7 days (393)
Last 30 days (1921)
Last 365 days (24057)
2024 (23242)
2023 (28220)
2022 (37973)
2021 (40238)
2020 (38230)
2019 (31605)
2018 (23945)
2017 (23273)
2016 (22000)
2015 (26342)
2014 (19973)
2013 (16604)
2012 (17926)
2011 (18541)
2010 (17313)
Location
Africa (420)
Arizona (116)
Asia (27938)
Australia (4719)
California (2443)
Canada (975)
China (158)
Colorado (126)
Connecticut (114)
Europe (59368)
Florida (339)
Georgia (98)
Illinois (236)
Indiana (130)
Japan (64)
Kansas (81)
Maryland (370)
Massachusetts (1803)
Michigan (154)
Minnesota (227)
New Jersey (702)
New York (662)
North Carolina (524)
Northern California (1079)
Ohio (97)
Pennsylvania (497)
South America (656)
Southern California (970)
Texas (352)
Utah (66)
Washington State (276)
463,636 Results for "biospecifics technologies corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
NanoString Technologies to Be Acquired by Bruker Corporation
NanoString Technologies, Inc. (“NanoString” or “the Company”) today announced that substantially all of its assets will be acquired by Bruker Corporation (“Bruker”), a global life science analytical instrument company, for approximately $392.6 million in cash consideration, plus the assumption of certain liabilities.
April 17, 2024
·
6 min read
Business
GT Medical Technologies, Inc. and Theragenics Corporation Forge Distribution Partnership for Cesium-131
GT Medical Technologies, Inc. today announced it has entered into a strategic distribution partnership with Theragenics Corporation® (Theragenics), a global leader in minimally invasive brachytherapy.
May 1, 2024
·
4 min read
BioForest
Simulab Corporation Announces New Technology in Medical Simulation With SimuSkin(TM)
Simulab Corporation proudly unveils its latest technology - SimuSkin.
January 18, 2024
·
2 min read
Business
Sensient Technologies Corporation Reports Results for the Quarter Ended March 31, 2024 and Raises Full Year Guidance
Sensient Technologies Corporation, a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, reported financial results for the first quarter ended March 31, 2024.
April 26, 2024
·
16 min read
Daxor Corporation to Exhibit at the Technology and Heart Failure Therapeutics Conference
Daxor Corporation today announces it will be exhibiting at the Technology and Heart Failure Therapeutics Conference (THT), which brings together the world’s leading experts in heart failure innovations at the Westin Boston Seaport in Boston, Massachusetts March 4-6, 2024.
February 26, 2024
·
3 min read
Business
Sensient Technologies Corporation Reports Results for the Quarter Ended December 31, 2023
Sensient Technologies Corporation, a leading provider of flavors and colors for the food, pharmaceutical, and personal care markets, reported financial results for the fourth quarter ended December 31, 2023.
February 8, 2024
·
22 min read
Press Releases
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
August 1, 2024
·
14 min read
Biotech Beach
Illumina releases 2023 Corporate Social Responsibility Report
Illumina Inc., a global leader in DNA sequencing and array-based technologies, published its fifth annual Corporate Social Responsibility Report.
May 28, 2024
·
4 min read
Genetown
Repligen Corporation to Present at Upcoming June 2024 Investor Conferences
Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it will be presenting at the following June investor conferences.
May 22, 2024
·
1 min read
Biotech Bay
Bruker Advances Magnet Technology for Broader Adoption of NMR in Academic and Biopharma Research, and Process Analytical Technologies
Bruker Corporation announces novel magnet technology and analytical solutions to support broad adoption of NMR in academic basic and clinical research, as well as in biopharma drug discovery, development and process analytical technologies.
April 8, 2024
·
4 min read
1 of 46,364
Next
